TELMI TAB 40CT 28’S

TELMI 40CT Tablets (28’s)

TELMI 40CT combines Telmisartan 40mg and Chlorthalidone 12.5mg, offering a dual-action approach to effectively manage hypertension (high blood pressure). This combination therapy is designed for patients whose blood pressure remains inadequately controlled with monotherapy.

• Telmisartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels by inhibiting the vasoconstrictor effects of angiotensin II, leading to lowered blood pressure.

• Chlorthalidone is a thiazide-like diuretic that reduces fluid retention by increasing urine output, further aiding in blood pressure reduction.

This combination enhances therapeutic efficacy, reduces the risk of cardiovascular events, and supports better patient adherence with once-daily dosing.

Key Benefits:

• Dual-action formulation for comprehensive blood pressure management

• Once-daily dosing for improved patient compliance

• Reduces risk of heart attack, stroke, and kidney damage

• Suitable for patients requiring combination antihypertensive therapy

Usage Instructions:
Take one tablet daily, preferably at the same time each day. The tablet can be taken with or without food. Swallow the tablet whole with water. Follow your healthcare provider’s instructions regarding dosage and duration.

Precautions:

• Not recommended during pregnancy, especially in the second and third trimesters.

• Use with caution in patients with kidney or liver disorders.

• Regular monitoring of blood pressure, kidney function, and electrolytes is advised during treatment.

• Avoid potassium supplements or salt substitutes without medical advice.

Note: Always use under medical supervision. Discontinue use if you experience any adverse reactions and consult your healthcare provider.